PTPI insider trading

OTC Markets OTCPK Healthcare

Petros Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
29
Last 90 days
3
Buys / sells
10% / 0%
Market cap
$254233

About Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

Company website: petrospharma.com

PTPI insider activity at a glance

FilingIQ has scored 29 insider transactions for PTPI since Dec 1, 2020. The most recent filing in our index is dated Jun 5, 2026.

Across the full history, 3 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PTPI insider trades is 55.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for PTPI?
FilingIQ tracks 29 Form 4 insider transactions for PTPI (Petros Pharmaceuticals, Inc.), covering filings from Dec 1, 2020 onwards. 3 of those were filed in the last 90 days.
Are PTPI insiders net buyers or net sellers?
Across the full Form 4 history for PTPI, 3 transactions (10%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PTPI insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PTPI in?
Petros Pharmaceuticals, Inc. (PTPI) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $254233.

Methodology & sources

Every PTPI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.